INDSWFTLAB vs LUPIN: Stock Comparison

Ind-Swift Laboratories Limited vs Lupin Limited

Live data: 22 July 2026, 2:55 PM IST • Source: NSE and company filings

Lupin Limited is the larger company by market capitalisation. Ind-Swift Laboratories Limited shows lower leverage and a higher net margin, while Lupin Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Ind-Swift Laboratories Limited and Lupin Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, INDSWFTLAB is more favourable on 3 of 13 scored metrics and LUPIN on 10These counts are context-free and are not an overall rating.

Key Differences

Market Cap
LUPIN is the larger company
₹1.1 L Cr vs ₹2,035 Cr
P/E Ratio
LUPIN has a lower P/E
21.56x vs 50.25x
P/B Ratio
INDSWFTLAB has a lower P/B
1.5x vs 5.12x
EPS
LUPIN has higher earnings per share
₹116.56 vs ₹4.84
Dividend Yield
LUPIN has a higher dividend yield
0.48% vs 0%
Revenue Growth (TTM YoY)
LUPIN has faster revenue growth
31.9% vs -66.6%
EPS Growth (TTM YoY)
LUPIN has faster EPS growth
89% vs -94.8%
Qtr Sales Growth
LUPIN has stronger quarterly sales growth
31.9% vs 22.8%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricINDSWFTLABLUPIN
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricINDSWFTLABLUPIN
Live Price₹234.31₹2,409.9
Day Change-1.38%-4.17%
Volume3.77 L10.19 L
52-Week High₹248.45₹2,529.5
52-Week Low₹87.15₹1,836.8
Distance from 52W High-5.69%-4.73%

Valuation

MetricINDSWFTLABLUPIN
Market Cap₹2,035 Cr₹1.1 L Cr
P/E Ratio50.25x21.56x
P/B Ratio1.5x5.12x
EPS₹4.84₹116.56
Book Value₹165.77₹491.29
Dividend Yield0%0.48%

Growth

MetricINDSWFTLABLUPIN
Revenue Growth (TTM YoY)-66.6%31.9%
EPS Growth (TTM YoY)-94.8%89%
Qtr Sales Growth22.8%31.9%
Qtr Profit Growth9.35%101%

Profitability & Leverage

MetricINDSWFTLABLUPIN
ROE3.87%29.1%
ROCE4.7%30.3%
Net Margin41.4%17.65%
Operating Margin7.03%31.5%
Debt to Equity0.01x0.29x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricINDSWFTLABLUPIN
Promoter Holding42.99% 3.49 pp46.57% 0.04 pp
FII Holding13.88% 0.45 pp21.71% 0.22 pp
DII Holding0% 0.68 pp25.32% 0.26 pp
Public Holding43.12% 2.38 pp6.11% 0.08 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Ind-Swift Laboratories Limited and Lupin Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.